A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trial
Maria Pearse, Carol Fraser-Browne, Ian D Davis, Gillian M Duchesne, Richard Fisher, Mark Frydenberg, Annette Haworth, Chakiath Jose, David J Joseph, Tee S Lim, John Matthews, Jeremy Millar, Mark Sidhom, Nigel A Spry, Colin I Tang, Sandra Turner, Scott G Williams, Kirsty Wiltshire, Henry H Woo, Andrew Kneebone
BJU International | WILEY-BLACKWELL | Published : 2014
Richard Fisher declares salary support via grants from the NHMRC, the Cancer Council Victoria and the New Zealand HRC. Carol Fraser-Browne declares salary support via a grant from the New Zealand HRC. The remaining authors' institutions receive grant funding from the NZ HRC, NHMRC, the CC NSW or the CC VIC.